These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8632732)

  • 1. Testosterone patches for hypogonadism.
    Med Lett Drugs Ther; 1996 May; 38(975):49-50. PubMed ID: 8632732
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of accurate testosterone testing in the treatment and management of male hypogonadism.
    Dobs AS
    Steroids; 2008 Dec; 73(13):1305-10. PubMed ID: 18639568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Ebert T, Jockenhövel F, Morales A, Shabsigh R. The current status of therapy for symptomatic late onset hypogonadism with transdermal testosterone gel. Eur Urol 2005;47:137-46.
    Ponholzer A; Rauchenwald M; Madersbacher S
    Eur Urol; 2005 Jul; 48(1):170-1; author reply 171. PubMed ID: 15967269
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interview with Prof. E. Nieschlag, Munster. How generously do you administer hormones?].
    Nieschlag E
    MMW Fortschr Med; 2002 Oct; 144(42):8. PubMed ID: 12533988
    [No Abstract]   [Full Text] [Related]  

  • 5. Androgel.
    Med Lett Drugs Ther; 2000 Jun; 42(1080):49-51. PubMed ID: 10859732
    [No Abstract]   [Full Text] [Related]  

  • 6. [Scrotal testosterone patches: a good addition to therapeutic options for hypogonadal men].
    Asscheman H; Gooren LJ
    Ned Tijdschr Geneeskd; 2000 Apr; 144(18):847-50. PubMed ID: 10816775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone gel shows promise in Phase III trial.
    AIDS Alert; 1999 Jun; 14(6):67. PubMed ID: 11366410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience using the Androderm testosterone transdermal system in hypogonadal adolescents and young men with beta-thalassemia major.
    De Sanctis V; Vullo C; Urso L; Rigolin F; Cavallini A; Caramelli K; Daugherty C; Mazer N
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():891-900. PubMed ID: 10091163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The key role of testosterone in male hypogonadism].
    Arver S; Lehtihet M
    Lakartidningen; 2009 Sep 23-29; 106(39):2460-4. PubMed ID: 19852166
    [No Abstract]   [Full Text] [Related]  

  • 10. Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism: is there a link?
    Tsujimura A; Takada S; Matsuoka Y; Nakayama J; Takao T; Miyagawa Y; Sonoda M; Nishizawa H; Iwahashi H; Funahashi T; Nonomura N; Okuyama A
    Int J Urol; 2009 Oct; 16(10):830-5. PubMed ID: 19719531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction.
    Mulhall JP; Valenzuela R; Aviv N; Parker M
    Urology; 2004 Feb; 63(2):348-52; discussion 352-3. PubMed ID: 14972487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to: Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
    Morgentaler A
    Int J Impot Res; 2008; 20(3):331; author reply 332. PubMed ID: 18475269
    [No Abstract]   [Full Text] [Related]  

  • 13. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function.
    Chiang HS; Hwang TI; Hsui YS; Lin YC; Chen HE; Chen GC; Liao CH
    Int J Impot Res; 2007; 19(4):411-7. PubMed ID: 17538639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel.
    Ebert T; Jockenhövel F; Morales A; Shabsigh R
    Eur Urol; 2005 Feb; 47(2):137-46. PubMed ID: 15661407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Between physiologic aging and dysfunction. How much testosterone does a man need?].
    Volkert R
    MMW Fortschr Med; 2005 Mar; 147(11):4-5. PubMed ID: 15803840
    [No Abstract]   [Full Text] [Related]  

  • 16. [Androgen substitution in endocrine testicales insufficiency].
    Karl HJ
    Internist (Berl); 1972 Jul; 13(7):276-80. PubMed ID: 4559268
    [No Abstract]   [Full Text] [Related]  

  • 17. Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents.
    Seftel A
    Int J Impot Res; 2007; 19(1):2-24. PubMed ID: 16193074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone treatment comes of age: new options for hypogonadal men.
    Nieschlag E
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):275-81. PubMed ID: 16918944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with Andriol Testocaps--the first Austrian surveillance study on the treatment of late-onset hypogonadism.
    Jungwirth A; Plas E; Geurts P
    Aging Male; 2007 Dec; 10(4):183-7. PubMed ID: 18033627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial comment: hypogonadism among HIV-infected men--a common condition.
    Crum-Cianflone NF
    AIDS Read; 2006 Jul; 16(7):346-7. PubMed ID: 16874914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.